(Q46464191)

22 December 2017

title

Calpain inhibition and insulin action in cultured human muscle cells (English)

1 reference

22 December 2017

author name string

Logie LJ

1

1 reference

22 December 2017

Brown AE

2

1 reference

22 December 2017

Yeaman SJ

3

1 reference

22 December 2017

Walker M

4

1 reference

22 December 2017

publication date

16 February 2005

1 reference

22 December 2017

Molecular Genetics and Metabolism

published in

1 reference

22 December 2017

volume

85

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

54-60

1 reference

22 December 2017

Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Variation in the calpain-10 gene affects blood glucose levels in the British population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Calpains play a role in insulin secretion and action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Reduced skeletal muscle calpain-10 transcript level is due to a cumulative decrease in major isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Regulation of glycogen synthesis by amino acids in cultured human muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Control of glycogen synthesis by glucose, glycogen, and insulin in cultured human muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Isolation and characterization of human muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.01.003

10.1016/J.YMGME.2005.01.003

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017